Investigating ways to reactivate a gene to treat Rett Syndrome
Epigenetic and Neuronal Mechanisms of MECP2 Reactivation to rescue Rett Syndrome
This study is looking at new ways to help people with Rett Syndrome by using special tools to turn on a gene that isn’t working properly, with the hope of easing their symptoms and improving their lives.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10902891 on NIH RePORTER |
What this research studies
This research focuses on Rett Syndrome, a severe neurodevelopmental disorder caused by mutations in the MeCP2 gene. The study aims to explore innovative methods to reactivate the silenced, functional allele of this gene using CRISPR-based epigenome editing tools. By targeting specific areas of the genome, the researchers hope to improve the expression of the MeCP2 gene without the adverse effects associated with global reactivation. The ultimate goal is to understand the mechanisms behind this reactivation and its potential to alleviate symptoms in affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are females diagnosed with Rett Syndrome who have mutations in the MeCP2 gene.
Not a fit: Patients with Rett Syndrome who do not have mutations in the MeCP2 gene or those with other unrelated neurodevelopmental disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that significantly improve the quality of life for patients with Rett Syndrome.
How similar studies have performed: While there have been successful applications of CRISPR technology in other genetic disorders, the specific approach of targeted MeCP2 reactivation in Rett Syndrome is still novel and untested.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Pan, Richard Li Cheng — Columbia University Health Sciences
- Study coordinator: Pan, Richard Li Cheng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.